Invivyd (IVVD) Metrics: History & Chart

Invivyd, Inc.(IVVD)

Biotechnology · New Haven, CT

$0.82-0.02 (-2.16%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

About Invivyd, Inc.

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.

New Haven, CT

122 employees

www.invivyd.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Marc William Elia

View full financials

Third-Party DCF Estimate (FMP)	$10.00
Price Gap vs Third-Party Estimate	+1091.07%

7D Total Return	-11.66%
30D Total Return	+1.60%
YTD Total Return	-66.02%
1Y Total Return	-27.66%
3Y Total Return	-48.52%
5Y Total Return	-97.37%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-66.02%
2025	+457.44%
2024	-88.75%
2023	+162.67%
2022	-79.34%
2021	N/A

CAGR TTM	-27.54%
CAGR 3Y	-19.85%
CAGR 5Y	-51.69%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

IVVD Valuation Metrics

IVVD Stock Price Metrics

IVVD Dividend Metrics

IVVD Growth Rate Metrics

IVVD Discounted Cash Flow Metrics

IVVD Returns By Period

IVVD Yearly Returns

IVVD Average Annual Returns By Period (CAGR)

IVVD Revenue Metrics

IVVD PE Ratio Metrics

IVVD PS Ratio Metrics

IVVD PB Ratio Metrics

IVVD Price to Free Cash Flow Ratio Metrics

IVVD Debt to Equity Ratio Metrics

IVVD PEG Ratio Metrics

IVVD FCF Yield

IVVD Earnings Yield

IVVD EBITDA Yield

IVVD OCF Yield

IVVD EV/EBIT Ratio Metrics

IVVD EV/EBITDA Ratio Metrics

IVVD EV/Assets Ratio Metrics

IVVD EV/Sales Ratio Metrics

IVVD Current Ratio Metrics

IVVD Quick Ratio Metrics

IVVD ROIC Metrics

IVVD Return on Assets Metrics

IVVD Return on Equity Metrics

IVVD Net Profit Margin Metrics

IVVD Gross Profit Margin Metrics

IVVD Tax Rate Metrics

PS Ratio	4.61
PS Ratio Avg TTM	5.34
PS Ratio Avg 3Y	4.97
Current VS TTM Avg	-13.73%
Current VS 3Y Avg	-7.33%
Current VS 5Y Avg	-7.33%

PB Ratio	1.49
PB Ratio Avg TTM	2.48
PB Ratio Avg 3Y	1.41
Current VS TTM Avg	-39.83%
Current VS 3Y Avg	+5.73%
Current VS 5Y Avg	+48.69%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.05
Debt/Equity Ratio Avg TTM	0.04
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	+17.49%
Current VS 3Y Avg	+140.55%
Current VS 5Y Avg	+369.83%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.54
Ev/Assets Ratio Avg TTM	1.08
Ev/Assets Ratio Avg 3Y	0.75
Current VS TTM Avg	-49.97%
Current VS 3Y Avg	-27.62%
Current VS 5Y Avg	+1.57%

Ev/Sales Ratio	2.01
Ev/Sales Ratio Avg TTM	3.13
Ev/Sales Ratio Avg 3Y	2.52
Current VS TTM Avg	-35.76%
Current VS 3Y Avg	-20.28%
Current VS 5Y Avg	-20.28%

Current Ratio	5.87
Current Ratio Avg TTM	4.68
Current Ratio Avg 3Y	4.85
Current VS TTM Avg	+25.49%
Current VS 3Y Avg	+21.03%
Current VS 5Y Avg	-17.26%

Quick Ratio	5.86
Quick Ratio Avg TTM	4.51
Quick Ratio Avg 3Y	4.75
Current VS TTM Avg	+29.89%
Current VS 3Y Avg	+23.44%
Current VS 5Y Avg	-16.52%

ROIC	(59.90%)
ROIC Avg 3Y	(137.90%)
ROIC Avg 5Y	(69.69%)
Current VS 3Y Avg	+56.56%
Current VS 5Y Avg	+14.04%
Current VS 10Y Avg	+42.85%

ROA	(49.04%)
ROA Avg TTM	(13.08%)
ROA Avg 3Y	(16.84%)
Current VS TTM Avg	-275.06%
Current VS 3Y Avg	-191.18%
Current VS 5Y Avg	-249.27%

ROE	(59.27%)
ROE Avg TTM	(88.18%)
ROE Avg 3Y	(133.12%)
Current VS TTM Avg	+32.79%
Current VS 3Y Avg	+55.48%
Current VS 5Y Avg	+13.04%

Net Profit Margin	(183.90%)
Net Profit Margin Avg TTM	(176.09%)
Net Profit Margin Avg 3Y	(150.93%)
Current VS TTM Avg	-4.43%
Current VS 3Y Avg	-21.85%
Current VS 5Y Avg	-201.73%

Gross Profit Margin	91.35%
Gross Pft Margin Avg TTM	91.82%
Gross Pft Margin Avg 3Y	64.15%
Current VS TTM Avg	-0.52%
Current VS 3Y Avg	+42.40%
Current VS 5Y Avg	+130.03%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A